menu
    • menu

    Company profile for Altesa Biosciences

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Altesa Biosciences, Inc., is a clinical-stage biopharmaceutical company developing drugs to treat RNA viruses, which are responsible for 80% of viral diseases worldwide. Among these viruses are Rhinovirus (primary cause of the common cold), Influenza, Respiratory Syncytial Virus (RSV), Dengue virus, Yellow Fever virus, Ebola virus, and SARS-CoV-2 (COVID-19).Altesa’s mission is to accelerate the clinical development and comme...
    Altesa Biosciences, Inc., is a clinical-stage biopharmaceutical company developing drugs to treat RNA viruses, which are responsible for 80% of viral diseases worldwide. Among these viruses are Rhinovirus (primary cause of the common cold), Influenza, Respiratory Syncytial Virus (RSV), Dengue virus, Yellow Fever virus, Ebola virus, and SARS-CoV-2 (COVID-19).Altesa’s mission is to accelerate the clinical development and commercialization of the DRIVE’s next six molecules that could follow in the footsteps of their previous blockbusters.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Altesa BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1930 Harvard Street, College Park, GA 30337
    Telephone
    Telephone
    703 618 2108
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://altesabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altesa BioSciences Closes $75M Oversubscribed Series B
    Altesa BioSciences Closes $75M Oversubscribed Series B

    19 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-closes-oversubscribed-75-million-series-b-financing-to-transform-treatment-of-chronic-lung-diseases-302692076.html

    PR NEWSWIRE
    19 Feb 2026
    Share Share
    Altesa Bio Shows Vapendavir Benefits In Rhinovirus COPD Study
    Altesa Bio Shows Vapendavir Benefits In Rhinovirus COPD Study

    28 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-presents-findings-demonstrating-beneficial-effects-of-vapendavir-for-treating-rhinovirus-infections-in-copd-challenge-study-302568959.html

    PR NEWSWIRE
    28 Sep 2025
    Share Share
    Altesa Bio Late-Breaker Presentation Chosen for ERS Congress 2025
    Altesa Bio Late-Breaker Presentation Chosen for ERS Congress 2025

    24 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-selected-for-late-breaker-presentation-at-the-european-respiratory-society-ers-international-congress-2025-302513293.html

    PR NEWSWIRE
    24 Jul 2025
    Share Share
    Giroir Commends Formation of Congressional BIOTech Caucus
    Giroir Commends Formation of Congressional BIOTech Caucus

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/giroir-commends-formation-of-congressional-biotech-caucus-302501433.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Former Trump Health Official Praises FDA's Drug Review Plan
    Former Trump Health Official Praises FDA's Drug Review Plan

    23 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fdas-accelerated-drug-review-plan-praised-by-former-senior-trump-health-official-302488825.html

    PR NEWSWIRE
    23 Jun 2025
    Share Share
    VirTus Respiratory Research Ltd study advances Altesa BioSciences
    VirTus Respiratory Research Ltd study advances Altesa BioSciences

    07 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250507489716/en/Results-from-the-VirTus-Respiratory-Research-Ltd-Human-Rhinovirus-Challenge-Model-Used-to-Advance-Altesa-BioSciences-Lead-Medicine-into-Advanced-Clinical-Trials

    BUSINESSWIRE
    07 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search